Home
  • Rankings
  • Fortune 500 India
    Most Powerful Women
    The Next 500
    Forty Under Forty
    Best B-Schools
    MNC 500
  • Profiles
  • Companies
    People
  • Business
  • Markets
  • Cryptocurrency
    IPO
    Stock Market
  • Economy
  • Personal Finance
  • Tax
    Mutual Funds
    Banking
  • Opinion
    Technology
    Auto
    Lifestyle
    Long Reads
    First Edit
    Ideas
    Buy on Amazon
    Magazine Annual Subscription
  • Archives
  • Enterprise
    Investing
    Macro
    Infographics
  • Home
    • News
      • Business
      • Markets
      • Economy
      • Personal Finance
      • Opinion
      • Technology
      • Auto
      • Lifestyle
    • Media
      • Videos
      • Short Videos
      • Visual Stories
    • Magazine
      • June 2025
      • May 2025
      • April 2025
      • March 2025
      • February 2025
      • January 2025
    • Rankings
      • Fortune 500 India
      • Most Powerful Women
      • The Next 500
      • Forty Under Forty
      • Best B-Schools
      • MNC 500
    • Profiles
      • Companies
      • People

Bharat Biotech

(22 search results)

Bharat Biotech in-licenses GSK vaccine candidate for bacterial diarrhoea

Bharat Biotech in-licenses GSK vaccine candidate for bacterial diarrhoea

Jun 12, 2025 5:43pm IST
Bharat Biotech's oral cholera vaccine shows promising results in Phase III clinical trials

Bharat Biotech's oral cholera vaccine shows promising results in Phase III clinical trials

May 21, 2025 4:30pm IST
Bharat Biotech readying Tuberculosis, Cholera vaccines

Bharat Biotech readying Tuberculosis, Cholera vaccines

Jul 10, 2024 6:58pm IST
India's first nasal Covid vaccine iNCOVACC launched; priced at ₹325/dose

India's first nasal Covid vaccine iNCOVACC launched; priced at ₹325/dose

Jan 27, 2023 11:48am IST
Bharat Biotech's Covid-19 nasal vaccine to cost ₹800 in pvt market, ₹325 for govt supplies

Bharat Biotech's Covid-19 nasal vaccine to cost ₹800 in pvt market, ₹325 for govt supplies

Dec 27, 2022 3:12pm IST
Bharat Biotech’s intra-nasal vaccine approved as primary, heterologous booster

Bharat Biotech’s intra-nasal vaccine approved as primary, heterologous booster

Nov 29, 2022 12:05pm IST
Bharat Biotech's intranasal Covid-19 vaccine approved for restricted use

Bharat Biotech's intranasal Covid-19 vaccine approved for restricted use

Sep 6, 2022 4:31pm IST
$19.3 million to Bharat Biotech consortium for ‘variant-proof’ Covid vaccine

$19.3 million to Bharat Biotech consortium for ‘variant-proof’ Covid vaccine

May 11, 2022 7:31pm IST
Bharat Biotech's US partner to commercialise Covaxin in Mexico

Bharat Biotech's US partner to commercialise Covaxin in Mexico

Apr 19, 2022 9:32am IST
Krishna Ella's Sapigen, Science Ministry partner for malaria, Covid-19 nasal vaccine

Krishna Ella's Sapigen, Science Ministry partner for malaria, Covid-19 nasal vaccine

Mar 28, 2022 9:54am IST
HomeTopicBharat Biotech
Follow us
Published by the RP-Sanjiv Goenka Group, Fortune India - the Indian edition of Fortune magazine - sets the benchmark for editorial excellence and thought leadership in Indian business journalism.
Rankings
  • Fortune 500 India
  • Most Powerful Women
  • The Next 500
  • Forty Under Forty
  • Best B-Schools
  • MNC 500
Profiles
  • Companies
  • People
Most Read Sections
  • Business
  • Markets
  • Economy
  • Personal Finance
  • Opinion
Media
  • Videos
  • Short Videos
  • Visual Stories
Magazines
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • Privacy & Cookie Policy
  • Terms of Use
  • Vision & Core Values
  • Contact Us
© 2025 Fortune India. All Rights Reserved.